Nuvation Bio Inc. Increase (Decrease) in Prepaid Expense
Nuvation Bio Inc. (NUVB) reported Increase (Decrease) in Prepaid Expense of $2.33 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2026-08-06
- Nuvation Bio Inc. increase (decrease) in prepaid expense for the quarter ending 2026-06-30 was -$2.11M.
- Nuvation Bio Inc. increase (decrease) in prepaid expense for the quarter ending 2026-03-31 was $4.44M, a 287.76% increase year-over-year.
- Nuvation Bio Inc. increase (decrease) in prepaid expense for the quarter ending 2025-12-31 was $2.61M.
- Nuvation Bio Inc. increase (decrease) in prepaid expense for the quarter ending 2025-09-30 was $669.00K, a 88.06% decline year-over-year.
- Nuvation Bio Inc. increase (decrease) in prepaid expense for fiscal 2025 was $4.26M, a 41.69% increase from fiscal 2024.
- Nuvation Bio Inc. increase (decrease) in prepaid expense for fiscal 2024 was $3.01M.
- Nuvation Bio Inc. increase (decrease) in prepaid expense for fiscal 2023 was -$2.30M, a 1399.44% decline from fiscal 2022.
- Nuvation Bio Inc. increase (decrease) in prepaid expense for fiscal 2022 was $177.00K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 5 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 6 month as first filed | Increase (Decrease) in Prepaid Expense 8 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.33M 10-Q · filed 2026-08-06 | $4.93M derived: sum of 3 quarters · filed 2026-08-06 | $5.60M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $4.44M 10-Q · filed 2026-05-04 | $7.05M derived: sum of 2 quarters · filed 2026-05-04 | $7.71M derived: sum of 3 quarters · filed 2026-05-04 | $7.56M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $2.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $3.28M derived: sum of 2 quarters · filed 2026-03-02 | $3.12M derived: sum of 3 quarters · filed 2026-08-06 | $4.26M 10-K · filed 2026-03-02 | |||
| 2025-09-30 | $669.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $511.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.66M 10-Q · filed 2025-11-03 | -$2.67M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | -$158.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $986.00K 10-Q · filed 2026-08-06 | -$3.34M derived: sum of 3 quarters · filed 2026-08-06 | $2.26M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $1.14M 10-Q · filed 2026-05-04 | -$3.18M derived: sum of 2 quarters · filed 2026-05-04 | $2.42M derived: sum of 3 quarters · filed 2026-05-04 | -$1.12M derived: sum of 4 quarters · filed 2026-05-04 | |||
| 2024-12-31 | -$4.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.28M derived: sum of 2 quarters · filed 2026-03-02 | -$2.27M derived: sum of 3 quarters · filed 2026-03-02 | $3.01M 10-K · filed 2026-03-02 | |||
| 2024-09-30 | $5.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $2.06M derived: sum of 2 quarters · filed 2025-11-03 | $7.34M 10-Q · filed 2025-11-03 | $5.88M derived: sum of 4 quarters · filed 2025-11-03 | |||
| 2024-06-30 | -$3.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.73M 10-Q · filed 2025-08-07 | $1.73M 10-Q · filed 2024-08-05 | $275.00K derived: sum of 3 quarters · filed 2025-08-07 | -$280.00K derived: sum of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | $5.28M 10-Q · filed 2025-05-07 | $3.82M derived: sum of 2 quarters · filed 2025-05-07 | $3.27M derived: sum of 3 quarters · filed 2025-05-07 | $3.11M derived: sum of 4 quarters · filed 2025-05-07 | |||
| 2023-12-31 | -$1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$2.01M derived: sum of 2 quarters · filed 2025-03-06 | -$2.16M derived: sum of 3 quarters · filed 2025-03-06 | -$2.30M 10-K · filed 2025-03-06 | |||
| 2023-09-30 | -$555.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$706.00K derived: sum of 2 quarters · filed 2024-11-06 | -$843.00K 10-Q · filed 2024-11-06 | -$2.12M derived: sum of 4 quarters · filed 2024-11-06 | |||
| 2023-06-30 | -$151.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$288.00K 10-Q · filed 2024-08-05 | -$1.56M derived: sum of 3 quarters · filed 2024-08-05 | -$4.27M derived: sum of 4 quarters · filed 2024-08-05 | |||
| 2023-03-31 | -$137.00K 10-Q · filed 2024-05-14 | -$1.41M derived: sum of 2 quarters · filed 2024-05-14 | -$4.12M derived: sum of 3 quarters · filed 2024-05-14 | -$4.16M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | -$1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$3.98M derived: sum of 2 quarters · filed 2024-02-29 | -$4.02M derived: sum of 3 quarters · filed 2024-02-29 | $177.00K 10-K · filed 2024-02-29 | |||
| 2022-09-30 | -$2.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$2.75M derived: sum of 2 quarters · filed 2023-11-02 | $1.45M 10-Q · filed 2023-11-02 | -$2.75M derived: sum of 4 quarters · filed 2023-11-02 | |||
| 2022-06-30 | -$43.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $4.16M 10-Q · filed 2023-08-03 | -$48.00K derived: sum of 3 quarters · filed 2023-08-03 | -$1.51M derived: sum of 4 quarters · filed 2023-08-03 | |||
| 2022-03-31 | $4.20M 10-Q · filed 2023-05-04 | -$5.00K derived: sum of 2 quarters · filed 2023-05-04 | -$1.46M derived: sum of 3 quarters · filed 2023-05-04 | -$2.13M derived: sum of 4 quarters · filed 2023-05-04 | |||
| 2021-12-31 | -$4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$5.66M derived: sum of 2 quarters · filed 2023-03-15 | -$6.33M derived: sum of 3 quarters · filed 2023-03-15 | -$2.42M 10-K · filed 2023-03-15 | |||
| 2021-09-30 | -$1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$2.13M derived: sum of 2 quarters · filed 2022-11-03 | $1.79M 10-Q · filed 2022-11-03 | ||||
| 2021-06-30 | -$667.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $3.25M 10-Q · filed 2022-08-04 | -$3.25M 10-Q · filed 2021-08-12 | ||||
| 2021-03-31 | $3.91M 10-Q · filed 2022-05-09 | ||||||
| 2020-12-31 | $339.09K 10-K/A · filed 2021-05-21 | ||||||
| 2020-09-30 | $400.63K 10-Q · filed 2020-11-16 | ||||||
| 2020-06-30 | -$1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$292.00K 10-Q · filed 2021-08-12 | |||||
| 2020-03-31 | $1.20M 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |